IL6 and atherosclerosis: AOPPs are reported to trigger inflammatory mechanisms, including cytokines (IL-6, IL-1), including macrophages, T lymphocytes, and mast cells, initiating the atherosclerosis process and serving as an early biomarker for atherogenesis [30–32].